superficial esophageal cancer
Conditions
Interventions
None listed
Sponsors
Nippon Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patients who underwent esophageal ESD at participating institutions and whose endoscopically observed circumferential mucosal defect was between 50% and 75% immediately after esophageal ESD 2. patients aged 20 years or older at the time of esophageal ESD
Exclusion criteria
Exclusion criteria: 1. esophageal ESD performed on multiple esophageal lesions at the same time and multiple mucosal defects with a circumference of 50% or more on endoscopic visualization 2. cases with intraoperative perforation 2. cases of intraoperative perforation 3. patients who received steroids before the surgery 4. patients with a history of esophageal stricture not caused by esophageal ESD 5. patients who refused to participate in this study. 6. other patients whom the principal investigator or research assistant judged to be inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factors in appearance of stenosis and symptoms of stenosis after esophageal ESD. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate (1) stenosis rate, (2) stenosis symptom occurrence rate, and (3) adverse events other than stenosis-related events (postoperative bleeding, delayed perforation, etc.) in the steroid use/non-use group. | — |
Countries
Japan
Contacts
Public ContactTsugumi Habu
Nippon Medical School, Graduate School of Medicine Department of Gastroenterology
Outcome results
None listed